» Articles » PMID: 30320563

Diagnostic Performance of Thyroid Imaging Reporting and Data System (TI-RADS) Alone and in Combination with Contrast-enhanced Ultrasonography for the Characterization of Thyroid Nodules

Overview
Publisher Sage Publications
Date 2018 Oct 16
PMID 30320563
Citations 14
Authors
Affiliations
Soon will be listed here.
Abstract

Background: The thyroid imaging reporting and data system (TI-RADS), classified and determined the risk of thyroid nodule malignancy with ultrasound scanning. Contrast-enhanced ultrasound (CEUS) is newly developed methods which could measure perfusion features.

Objective: The aim of the study was to investigate the value of diagnosing thyroid nodules using TI-RADS combined with CEUS and determine whether improvements were made to the diagnostic accuracy.

Methods: The features of conventional ultrasonography (US) and CEUS ion 117 case of thyroid nodules samples, which were confirmed by fine-needle aspiration and/or surgery, were retrospectively analyzed. The independent US and CEUS predictors for malignancy were determined and quantified using logistic regression analysis. The receiver operating characteristic (ROC) curve analysis was used to compare the diagnostic efficiency of each method in predicting malignant solid thyroid nodules.

Results: The TI-RADS + CEUS combination had the highest accuracy (94.02%), sensitivity (94.74%), specificity (93.33%), PPV (93.10%) and NPV (94.92%), significantly greater than that of TI-RADS alone and CEUS alone (χ2 = 8.746, P < 0.001; χ2 = 9.825, P < 0.001). The area under the ROC curve (AUC) of TI-RADS alone, CEUS alone, and combined use of TI-RADS and CEUS were 0.871, 0.884, and 0.942, respectively. The following conventional US and CEUS features based on logistic regression analysis showed significant predictive value for thyroid malignant nodules: Obscure margin, calcification, hypoechoic, low enhancement, rim-like enhancement.

Conclusions: TI-RADS in combination with CEUS has superior diagnostic efficiency in the discrimination of benign and malignant thyroid lesions, compared with TI-RADS and CEUS alone.

Citing Articles

Integrated use of contrast-enhanced and grey-scale ultrasound in assigning American College of Radiology Thyroid Imaging-Reporting and Data System scores for characterisation of thyroid nodules: A prospective observational study.

Verma A, Krishna K A, Kumar I, Singh P, Kar A, Agrawal N Ultrasound. 2024; 32(3):140-149.

PMID: 39100794 PMC: 11292930. DOI: 10.1177/1742271X231225056.


Diagnostic value of qualitative and quantitative parameters of contrast-enhanced ultrasound for differentiating differentiated thyroid carcinomas from benign nodules.

Fan J, Tao L, Zhan W, Li W, Kuang L, Zhao Y Front Endocrinol (Lausanne). 2024; 14:1240615.

PMID: 38250738 PMC: 10797774. DOI: 10.3389/fendo.2023.1240615.


Contrast Enhancement Ultrasound Improves Diagnostic Accuracy for Thyroid Nodules: A Prospective Multicenter Study.

Li J, Dou J, Li H, Xiao F, Yu J, Xie M J Endocr Soc. 2023; 8(1):bvad145.

PMID: 38075563 PMC: 10699741. DOI: 10.1210/jendso/bvad145.


A machine learning-based sonomics for prediction of thyroid nodule malignancies.

Arabi M, Nazari M, Salahshour A, Jenabi E, Hajianfar G, Khateri M Endocrine. 2023; 82(2):326-334.

PMID: 37291392 DOI: 10.1007/s12020-023-03407-6.


The use of modified TI-RADS using contrast-enhanced ultrasound features for classification purposes in the differential diagnosis of benign and malignant thyroid nodules: A prospective and multi-center study.

Zhou P, Chen F, Zhou P, Xu L, Wang L, Wang Z Front Endocrinol (Lausanne). 2023; 14:1080908.

PMID: 36817602 PMC: 9929352. DOI: 10.3389/fendo.2023.1080908.